Skip to content
10-Q

Quarterly Report

Q Therapeutics, Inc.

0001193125-14-403654

← back to feed
Filed
Nov 7, 2014 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2014 · Oct 31, 2014 30.42M sh
Stockholders Equity Q3 2014 · Sep 30, 2014 $144.13K
Stockholders Equity Q3 2014 · Dec 31, 2013 −$3.04M
Current Liabilities Q3 2014 · Sep 30, 2014 $1.14M
Current Liabilities Q3 2014 · Dec 31, 2013 $3.3M
Current Assets Q3 2014 · Sep 30, 2014 $1.26M
Current Assets Q3 2014 · Dec 31, 2013 $221.53K
Total Assets Q3 2014 · Sep 30, 2014 $1.29M
Total Assets Q3 2014 · Dec 31, 2013 $257.04K
Revenue Q3 2014 · Sep 30, 2014 $167.24K
Revenue Q3 2014 · Sep 30, 2014 $669.86K
Revenue Q3 2014 · Sep 30, 2013 $12K
Revenue Q3 2014 · Sep 30, 2013 $24.29K
Capex Q3 2014 · Sep 30, 2013 $23.8K
Operating Cash Flow Q3 2014 · Sep 30, 2013 −$690.04K
Cash And Equivalents Q3 2014 · Sep 30, 2013 $330.37K
Cash And Equivalents Q3 2014 · Dec 31, 2012 $794.21K
Sga Expense Q3 2014 · Sep 30, 2013 $326.65K
Sga Expense Q3 2014 · Sep 30, 2013 $1.08M
Rd Expense Q3 2014 · Sep 30, 2013 $1.37M
Rd Expense Q3 2014 · Sep 30, 2013 $1.64M
Net Income Q3 2014 · Sep 30, 2013 −$1.76M
Net Income Q3 2014 · Sep 30, 2013 −$2.77M
Operating Income Q3 2014 · Sep 30, 2013 −$1.69M
Operating Income Q3 2014 · Sep 30, 2013 −$2.7M
Gross Profit Q3 2014 · Sep 30, 2013 $7.2K
Gross Profit Q3 2014 · Sep 30, 2013 $19.49K
Cost Of Revenue Q3 2014 · Sep 30, 2013 $4.8K
Cost Of Revenue Q3 2014 · Sep 30, 2013 $4.8K